Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05430672

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05430672
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05430672. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06 (anticipated); primary completion 2023-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection
Intervention (Device)
The Thoracic Aortic Stent Graft System (Zylox-Tonbridge Medical Technology Co., Ltd. )
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05430672
Content hash
7d95d344e69dc9f602355a3ce19bb9a6ea7e311e4a200cd9fce43d2772697efb